Flow Pharma

07/15/2022

From our team to your scrolling feed this is Dr. Tikoes Blankenberg, M.D.
FCAP and Chairman of the Board here at Flow Pharma.

Dr. Blankenberg is a board-certified pathologist and the senior partner at Shasta Pathology Associates. He attended Medical School at the University of California, Los Angeles, after receiving his bachelor’s degree in Biomedical Engineering, Materials Science option, from Northwestern University, Evanston, Illinois.

Dr. Blankenberg subsequently completed his pathology residency at the University of California, Davis and a surgical pathology fellowship at Stanford University. He has served as Chief of Staff for St Elizabeth’s Hospital, Red Bluff, California and has served on the Community Board of Dignity Health, Northern California Service Area.

07/08/2022

Meet our team, Dr. Herst

After completing his B.A. in Bacteriology at U.C. Berkeley in 1978, Dr. Herst worked at the Naval Bioscience Laboratory in Oakland, CA.

His research led to the FDA approval of Miconazole and Ketoconazole as treatments for fungal infections in humans. After receiving his MPH from the University of California, he worked at Cetus Corporation as a key member of the immunology team that advanced Betaseron and interleukin-2 toward human clinical trials. He earned his Ph.D. in Cancer Biology from Northwestern in 1989 followed by a post-doctoral fellowship at MD Anderson Cancer Center.

Over the next fifteen years he worked at a variety of positions in high complexity clinical labs both in the USA and in Europe, as well as in the development of medical devices at Aradigm Corporation.

07/04/2022

Happy 4th of July from the team at Flow Pharma!

05/31/2022

In April of 2022 there was an Ebola out break in the Republic of Congo. How would you stay safe? CDC

On April 23, 2022, the Ministry of Health in the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola virus disease (EVD) in Mbandaka health zone, Equateur Province.

05/30/2022

Happy Memorial Day! Today, we pay tribute to those brave soldiers who made the ultimate sacrifice in service to our nation. We'll never forget our country's fallen heroes.
•
Please keep yourself safe during this holiday and enjoy your friends and family.

Travel is rising, Covid-19 cases are down, and Memorial Day weekend is set to look more like it did before the pandemic upended life more than a year ago.

04/20/2022

Meet Flow Pharma’s Founder, CEO, Medical Director and Chief Medical Officer, Dr. Rubsamen.
•
Rubsamen holds an A.B. in Biochemistry and Computer Science from the University of California, Berkeley, an M.S. in Computer Science, an M.D. from Stanford University, and a Masters in Healthcare Management from the Harvard School of Public Health.
•
Dr. Rubsamen is currently a Clinical Associate Professor at the Case Western Reserve University School of Medicine.
He is a named inventor of more than 70 issued U.S. patents, and has over 10,000 citations to his collective work.
He Continuously leads this company through innovation.

03/30/2021

Check out our new office and lab in Cleveland, OH, the unique medical ecosystem supported by key allies at University Hospital where we will conduct our clinical trials and the Cleveland Clinic whose doctors are eager to learn more about our mission. Follow us here www.flowpharma.com

03/12/2021

Welcome Dr Tunde Otulana!

02/02/2021

Flow Pharma update. Learn more here www.strategicvaccines.com Please share.

12/10/2020

CEO Reid Rubsamen, MD, former Texas Governor Rick Perry plus senior management team from Lockheed Martin, Chancellor of Texas A&M and James Hill, M7TechGroup launch our new lab space for manufacturing in College Station, TX Flow Pharma owns 75% of this public private partnership.

11/19/2020

See our press release 11/19/20 about Lockheed Martin and Strategic Vaccines. See www.strategicvaccines.com which is 75% owned by Flow Pharma, Inc.